Skip to main content
Medcolcanna Organics Inc. logo

Medcolcanna Organics Inc. — Investor Relations & Filings

Ticker · MCCN ISIN · CA58406X1050 LEI · 549300TREPZ6YDG3UM68 CSE Manufacturing
Filings indexed 216 across all filing types
Latest filing 2025-03-03 Regulatory Filings
Country CA Canada
Listing CSE MCCN

About Medcolcanna Organics Inc.

https://www.medcolcanna.com

Medcolcanna Organics Inc. is a vertically integrated medical cannabis company operating through fully licensed facilities in Colombia. The company specializes in the cultivation, transformation, and global distribution of high-quality cannabis and derived products. Leveraging Colombia's natural competitive advantages, Medcolcanna produces raw materials, commodities, and finished goods, including pharmaceutical, cosmetic, nutraceutical, and bulk Active Pharmaceutical Ingredients (API). The company utilizes sound scientific research to develop proprietary genetics and formulations, ensuring products meet the highest global industry standards. It also offers production and extraction services to support local and international partners.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2025-03-03 English
News release - English.pdf
Regulatory Filings
2023-03-07 English
Certificate re dissemination to shareholders.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a short communication from TSX Trust Company confirming the mailing of proxy-related materials to registered securityholders. It mentions a proxy with notice-and-access notice and request for financial statements, but does not contain the proxy materials themselves or any financial data. The document is brief (1047 characters) and serves as an announcement of the mailing of proxy materials rather than the materials themselves. According to the 'Menu vs Meal' rule, such a document is classified as a Proxy Solicitation & Information Statement (PSI) related announcement or a Regulatory Filing (RNS). However, since it specifically confirms mailing of proxy materials, the best fit is Proxy Solicitation & Information Statement (PSI).
2022-10-14 English
Other.pdf
Regulatory Filings Classification · 100% confidence The document is a certificate of an officer (Chief Financial Officer) addressed to securities commissions regarding compliance with National Instrument 54-101 about communication with beneficial owners for a shareholder meeting. It certifies procedural compliance and timing related to proxy materials for a shareholder meeting. The document is short (1276 characters) and is primarily an officer certification letter, not containing financial data or substantive report content. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2022-10-14 English
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Form of Proxy for the Annual General and Special Meeting of Medcolcanna Organics Inc. It includes instructions for voting on resolutions such as the number of directors, election of directors, appointment of auditor, and adoption of an incentive stock option plan. It also references the Management Information Circular and provides details on how to access meeting materials electronically. The document is clearly related to shareholder voting and proxy solicitation for the AGM, not the AGM presentation materials themselves or the annual report. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length (7513 characters) and content confirm it is a proxy form and voting instructions, not a report or announcement of a report.
2022-10-14 English
Notice of meeting - English.pdf
AGM Information Classification · 95% confidence The document is a Notice of Annual General and Special Meeting of Shareholders for Medcolcanna Organics Inc. It details the date, time, location, and agenda of the meeting, including items such as receiving audited financial statements, electing directors, appointing auditors, and approving a stock option plan. It also includes instructions for shareholders on voting and proxy submission. The document does not contain the actual financial statements or detailed reports but serves as a formal notification to shareholders about the meeting and its agenda. Given its nature as a meeting notice, it fits the category of AGM Information (AGM-R). The document length is under 5,000 characters and it is clearly a notice rather than the full report or minutes of the meeting.
2022-10-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.